Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

American Trypanosomiasis

American Trypanosomiasis

Chagas disease, or American trypanosomiasis, is a vector-borne parasitic infection caused by Trypanosoma cruzi, a flagellated protozoan (kinetoplastid) of the family Trypanosomatidae. The disease is endemic in Latin America, although cases are increasingly reported worldwide due to human migration. Transmission most commonly occurs when feces of infected triatomine bugs contaminate bite wounds or mucosal surfaces; additional routes include congenital, transfusional, transplant-related, and oral...

Leishmaniasis

Leishmaniasis

Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...

Esophageal Achalasia

Esophageal Achalasia

Esophageal achalasia is a chronic neurogenic disorder characterized by impaired relaxation of the lower esophageal sphincter (LES) and absent or ineffective peristalsis in the distal esophagus. This leads to a functional obstruction without a physical blockage, despite significant disruption of esophageal motility.EtiologyAchalasia is caused by degeneration of the myenteric (Auerbach's) plexus, specifically the loss of inhibitory ganglion cells that produce vasoactive intestinal peptide (VIP)...

Malaria

Malaria

Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...

Infectious Diseases and Their Occurrence

Infectious Diseases and Their Occurrence

Infectious diseases appear in populations through various transmission patterns, influenced by pathogen characteristics, population immunity, environmental conditions, and social behavior. Understanding these patterns is essential for effective public health surveillance and intervention. These categories—sporadic, outbreak, epidemic, pandemic, and endemic—help frame the nature and scope of disease events.Sporadic diseases occur irregularly and infrequently, without a predictable temporal or...

Chronic Pancreatitis II: Collaborative Care

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Structural basis of the substrate specificity and instability in solution of a glycosidase from Lactobacillus plantarum.

Biochimica et biophysica acta. Proteins and proteomics·2017

Same author

The value of selected in vitro and in silico methods to predict acute oral toxicity in a regulatory context: results from the European Project ACuteTox.

Toxicology in vitro : an international journal published in association with BIBRA·2012

Same author

Neural computational prediction of oral drug absorption based on CODES 2D descriptors.

European journal of medicinal chemistry·2009

Same author

Cannabinoid system in neurodegeneration: new perspectives in Alzheimer's disease.

Mini reviews in medicinal chemistry·2009

Same author

Novel bronchodilators: synthesis, transamination reactions, and pharmacology of a series of pyrazino[2,3-c][1,2,6]thiadiazine 2, 2-dioxides.

Journal of medicinal chemistry·2000

Same author

Novel arylpyrazino[2,3-c][1,2,6]thiadiazine 2,2-dioxides as platelet aggregation inhibitors. 2. Optimization by quantitative structure-activity relationships.

Journal of medicinal chemistry·1999

Search research articles

Related Experiment Video

Updated: Jun 17, 2026

Demystifying In Vivo Bioluminescence Imaging of a Chagas Disease Mouse Model for Drug Efficacy Studies

Demystifying In Vivo Bioluminescence Imaging of a Chagas Disease Mouse Model for Drug Efficacy Studies

Published on: May 31, 2024

Chagas disease: progress and new perspectives.

F Sánchez-Sancho¹, N E Campillo, J A Páez

¹Instituto de Q. Médica, (CSIC). Juan de la Cierva, 3, 28006-Madrid, Spain.

Current Medicinal Chemistry

|December 18, 2009

Summary

Chagas disease, or American trypanosomiasis, affects millions. Current treatments for Trypanosoma cruzi infection are limited, prompting research into new drug discovery strategies and validated therapeutic targets. This review explores these advancements.

More Related Videos

Sexual Transmission of American Trypanosomes from Males and Females to Naive Mates

Sexual Transmission of American Trypanosomes from Males and Females to Naive Mates

Published on: January 27, 2019

In Vitro Drug Screening Against All Life Cycle Stages of Trypanosoma cruzi Using Parasites Expressing β-galactosidase

In Vitro Drug Screening Against All Life Cycle Stages of Trypanosoma cruzi Using Parasites Expressing β-galactosidase

Published on: November 5, 2021

Related Experiment Videos

Last Updated: Jun 17, 2026

Demystifying In Vivo Bioluminescence Imaging of a Chagas Disease Mouse Model for Drug Efficacy Studies

Demystifying In Vivo Bioluminescence Imaging of a Chagas Disease Mouse Model for Drug Efficacy Studies

Published on: May 31, 2024

Sexual Transmission of American Trypanosomes from Males and Females to Naive Mates

Sexual Transmission of American Trypanosomes from Males and Females to Naive Mates

Published on: January 27, 2019

In Vitro Drug Screening Against All Life Cycle Stages of Trypanosoma cruzi Using Parasites Expressing β-galactosidase

In Vitro Drug Screening Against All Life Cycle Stages of Trypanosoma cruzi Using Parasites Expressing β-galactosidase

Published on: November 5, 2021

Area of Science:

Infectious Diseases
Parasitology
Drug Discovery

Background:

Chagas disease, caused by Trypanosoma cruzi, impacts millions in endemic regions.
Current treatments (nifurtimox, benznidazole) have limited efficacy and toxic side effects, especially in the chronic stage.
There is a critical need for improved therapeutic options for American trypanosomiasis.

Purpose of the Study:

To review current knowledge on Chagas disease, including transmission, parasite biology, epidemiology, and treatments.
To focus on drug discovery strategies for Chagas disease, encompassing methodologies and target validation.
To discuss recent progress in identifying and validating novel drug targets.

Main Methods:

Review of existing literature on Chagas disease.
Analysis of drug discovery methodologies, including in vitro screening and rational drug design.
Examination of validated and emerging therapeutic targets for Trypanosoma cruzi.

Main Results:

Current treatments for Chagas disease are empirical and suboptimal.
Several key pathways and targets in Trypanosoma cruzi are being explored for drug development.
Emerging strategies include targeting sterol biosynthesis, proteases, and metabolic pathways.

Conclusions:

The development of novel therapeutics for Chagas disease is crucial due to limitations of current treatments.
Understanding Trypanosoma cruzi biochemistry facilitates rational drug design.
Continued research into validated targets and novel strategies holds promise for effective Chagas disease therapy.